“Sustained Complete Response to a Short Course of Subcutaneous Daratumumab in Multi-Refractory Immune Thrombocytopenia”. Mediterranean Journal of Hematology and Infectious Diseases 18, no. 1 (September 1, 2026): e2026069. Accessed September 2, 2026. https://www.mjhid.org/mjhid/article/view/6466.